---
document_datetime: 2025-12-19 13:20:36
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tuzulby-epar-all-authorised-presentations_en.pdf
document_name: tuzulby-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9379589
conversion_datetime: 2025-12-30 01:34:52.745869
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## MA (EU) number (Invented) name Strength Pharmaceutical Form Route of Administration Immediate Packaging Pack size

| EU/1/24/1907/001   | Tuzulby   | 20 mg   | Prolonged-release chewable tablet   | Oral use   | bottle (HDPE)   | 30 tablets   |
|--------------------|-----------|---------|-------------------------------------|------------|-----------------|--------------|
| EU/1/24/1907/002   | Tuzulby   | 30 mg   | Prolonged-release chewable tablet   | Oral use   | bottle (HDPE)   | 30 tablets   |
| EU/1/24/1907/003   | Tuzulby   | 40 mg   | Prolonged-release chewable tablet   | Oral use   | bottle (HDPE)   | 30 tablets   |
| EU/1/24/1907/004   | Tuzulby   | 20 mg   | Prolonged-release chewable tablet   | Oral use   | bottle (HDPE)   | 28 tablets   |
| EU/1/24/1907/005   | Tuzulby   | 30 mg   | Prolonged-release chewable tablet   | Oral use   | bottle (HDPE)   | 28 tablets   |
| EU/1/24/1907/006   | Tuzulby   | 40 mg   | Prolonged-release chewable tablet   | Oral use   | bottle (HDPE)   | 28 tablets   |